ACCELERATE
CLINICAL GENOMICS
OUR MISSION
Enable laboratories to launch clinical next generation genomics programs and promote collaboration for the advancement of medical science.
ABOUT US
Boston Lighthouse Innovations (BLI) was founded to commercialize the BioBeam Platform, leveraging advanced bioinformatics workflow expertise developed at The Massachusetts General Hospital Center for Integrated Diagnostics (MGH CID). The BioBeam Platform embodies commercial-grade solutions that optimize precision medicine programs and are built on a foundation of proven clinical applications.
OFFERINGS
The BioBeam Platform was designed for laboratory workflow and management, analytics, and reporting of next generation sequencing data.
-
BLI shares with MGH CID a goal to accelerate Clinical genomics.
OUR TECHNOLOGY
Our BioBeam Platform streamlines every aspect of a clinical next generation genomics (NGS) laboratory from accession, to providing clinical decision support, to final custom case signout.
Designed for precision and scalability, BioBeam integrates into clinical workflows, ensuring robust performance and regulatory compliance.
GET IN TOUCH
We’d love to discuss how the BioBeam Platform can accelerate clinical genomics in your laboratory...